UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies

Frontiers in immunology, 2024-03, Vol.15, p.1404085-1404085

2024

Volltextzugriff (PDF)

Staphylococcal Infections: Host and Pathogenic Factors

Microorganisms (Basel), 2021-05, Vol.9 (5), p.1080

Adhikari, Rajan P.

2021

Volltextzugriff (PDF)

Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia

PloS one, 2012-06, Vol.7 (6), p.e38567

2012

Volltextzugriff (PDF)

Inhibition of rot translation by RNAIII, a key feature of agr function

Molecular microbiology, 2006-08, Vol.61 (4), p.1038-1048

2006

Volltextzugriff (PDF)

Regulatory organization of the staphylococcal sae locus

Microbiology (Society for General Microbiology), 2008-03, Vol.154 (Pt 3), p.949-959

2008

Volltextzugriff (PDF)

Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs

PloS one, 2015-09, Vol.10 (9), p.e0137874

2015

Volltextzugriff (PDF)

Prevalence of agr Dysfunction among Colonizing Staphylococcus aureus Strains

The Journal of infectious diseases, 2008-10, Vol.198 (8), p.1171-1174

2008

Volltextzugriff (PDF)

Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries

Frontiers in immunology, 2024-04, Vol.15, p.1373367-1373367

2024

Volltextzugriff (PDF)

IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus

Frontiers in immunology, 2021-03, Vol.12, p.624310

2021

Volltextzugriff (PDF)

Mutations in agr Do Not Persist in Natural Populations of Methicillin-Resistant Staphylococcus aureus

The Journal of infectious diseases, 2010-11, Vol.202 (10), p.1593-1599

2010

Volltextzugriff (PDF)

Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralization

mAbs, 2022-12, Vol.14 (1), p.2083467-2083467

2022

Volltextzugriff (PDF)

Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models

Frontiers in immunology, 2022-05, Vol.13, p.893921-893921

2022

Volltextzugriff (PDF)

Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy

Toxins, 2014-03, Vol.6 (3), p.950-972

2014

Volltextzugriff (PDF)

A Critical Role for HlgA in Staphylococcus aureus Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System

Toxins, 2018-09, Vol.10 (9), p.377

2018

Volltextzugriff (PDF)

Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model

PloS one, 2013-06, Vol.8 (6), p.e65384

2013

Volltextzugriff (PDF)

Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot

Frontiers in cellular and infection microbiology, 2022-07, Vol.12, p.876898

2022

Volltextzugriff (PDF)

Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques

Frontiers in immunology, 2021-02, Vol.12, p.621754-621754

2021

Volltextzugriff (PDF)

Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)

Toxins, 2019-06, Vol.11 (6), p.339

2019

Volltextzugriff (PDF)

Nonsense Mutation in agrA Accounts for the Defect in agr Expression and the Avirulence of Staphylococcus aureus 8325-4 traP::kan

Infection and Immunity, 2007-09, Vol.75 (9), p.4534-4540

2007

Volltextzugriff (PDF)

Correction: Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs

PloS one, 2015-11, Vol.10 (11), p.e0143493-e0143493

2015

Volltextzugriff (PDF)

Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections

Vaccine, 2016-12, Vol.34 (50), p.6402-6407

2016

Volltextzugriff (PDF)

Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections

The Journal of infectious diseases, 2012-09, Vol.206 (6), p.915-923

2012

Volltextzugriff (PDF)

Efficacy of Active Immunization With Attenuated α-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia

The Journal of infectious diseases, 2020-01, Vol.221 (2), p.267-275

2020

Volltextzugriff (PDF)

Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax

Clinical and vaccine immunology, 2016-12, Vol.23 (12), p.918-925

2016

Volltextzugriff (PDF)

TBA 225 , a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens

Scientific reports, 2019-12, Vol.9 (1), p.3279

2019

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(51)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(30)
Staphylococcus Aureus
(26)
Immunology
(16)
Humans
(15)
Microbiology
(15)
Animals
(12)
Vaccines
(11)
Biological And Medical Sciences
(10)
Infectious Diseases
(10)
Virulence
(10)
Bacterial Proteins - Genetics
(9)
Female
(9)
Fundamental And Applied Biological Sciences. Psychology
(9)
Bacteriology
(8)
Staphylococcus Infections
(8)
Toxins
(8)
Antibodies
(7)
Leukocidin
(7)
Mice
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies

Staphylococcal Infections: Host and Pathogenic Factors

Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia

Inhibition of rot translation by RNAIII, a key feature of agr function

Regulatory organization of the staphylococcal sae locus

Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs

Prevalence of agr Dysfunction among Colonizing Staphylococcus aureus Strains

Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries

IBT-V02: A Multicomponent Toxoid Vaccine Protects Against Primary and Secondary Skin Infections Caused by Staphylococcus aureus

Mutations in agr Do Not Persist in Natural Populations of Methicillin-Resistant Staphylococcus aureus

Antigenic landscapes on Staphylococcus aureus pore-forming toxins reveal insights into specificity and cross-neutralization

Hyperimmune Targeting Staphylococcal Toxins Effectively Protect Against USA 300 MRSA Infection in Mouse Bacteremia and Pneumonia Models

Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy

A Critical Role for HlgA in Staphylococcus aureus Pathogenesis Revealed by A Switch in the SaeRS Two-Component Regulatory System

Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model

Evidence of Neutralizing and Non-Neutralizing Anti-Glucosaminidase Antibodies in Patients With S. Aureus Osteomyelitis and Their Association With Clinical Outcome Following Surgery in a Clinical Pilot

Safety and Immunogenicity of a 4-Component Toxoid-Based Staphylococcus aureus Vaccine in Rhesus Macaques

Rational Design of Toxoid Vaccine Candidates for Staphylococcus aureus Leukocidin AB (LukAB)

Nonsense Mutation in agrA Accounts for the Defect in agr Expression and the Avirulence of Staphylococcus aureus 8325-4 traP::kan

Correction: Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs

Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections

Lower Antibody Levels to Staphylococcus aureus Exotoxins Are Associated With Sepsis in Hospitalized Adults With Invasive S. aureus Infections

Efficacy of Active Immunization With Attenuated α-Hemolysin and Panton-Valentine Leukocidin in a Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia

Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax

TBA 225 , a fusion toxoid vaccine for protection and broad neutralization of staphylococcal superantigens

Suchergebnisse filtern